Parabilis Medicines Partners With Regeneron Pharmaceuticals to Develop Antibody-Helicon™ Conjugates Across Multiple Diseases Parabilis Medicines has entered into a major strategic research collaboration with Regeneron Pharmaceuticals aimed at advancing a new generation of targeted medicines designed to tackle some of…
Genentech Receives FDA Approval for Tecentriq in ctDNA-Guided Treatment of Muscle-Invasive Bladder Cancer Genentech announced that the U.S. Food and Drug Administration has approved both Tecentriq and Tecentriq Hybreza as adjuvant treatments for adult patients with muscle-invasive bladder cancer (MIBC)…
ICUS Supports New Sonography Training Standards Expanding Education in Contrast Enhanced Ultrasound International Contrast Ultrasound Society has expressed strong support for newly proposed accreditation standards that could significantly expand education and training in contrast enhanced ultrasound (CEUS) for future sonographers…
Glooko Receives FDA 510(k) Clearance for EndoTool IV Cloud Platform Glooko, Inc., a global digital health company specializing in diabetes management and glycemic safety solutions, has announced that the U.S. Food and Drug Administration has granted 510(k) clearance for EndoTool…
Next Health Opens New Peoria Location Offering Advanced Longevity and Preventive Care Services in Arizona Next Health, a provider of preventive wellness, longevity, and personalized health optimization services, has announced the grand opening of its newest location in Peoria, Arizona.…
Medisca and dsm–firmenich Collaborate to Broaden U.S. Access to Pharmaceutical-Grade Vitamin APIs for Compounding Pharmacies Medisca, a global provider of personalized pharmaceutical solutions and compounding technologies, has announced a strategic partnership with dsm–firmenich, an international manufacturer of pharmaceutical ingredients and…
Vetter Begins Building New Manufacturing Facility in Germany Vetter, a globally recognized Contract Development and Manufacturing Organization specializing in aseptic filling and pharmaceutical manufacturing services, has officially launched construction activities for its newest production facility in Saarlouis, Germany. The milestone…
Johnson & Johnson Launches “Generation Fine” Campaign to Encourage Better Conversations Around Depression Care and Remission Johnson & Johnson has launched Generation Fine, a new global awareness campaign focused on reshaping conversations around depression treatment and encouraging people living with…
Rapid Medical Reports Positive DISTALS Trial Results for TIGERTRIEVER 13 in Distal Stroke Treatment Rapid Medical, a medical technology company focused on advanced stroke treatment solutions, has announced full results from the DISTALS randomized clinical trial during the 11th European…
Viridian Therapeutics Plans Concurrent Public Offerings of Convertible Senior Notes Due 2032, Common Shares, and Series B Non-Voting Convertible Preferred Stock Viridian Therapeutics (Nasdaq: VRDN), a clinical-stage biopharmaceutical company focused on developing innovative therapies for autoimmune and rare diseases, has…
RestorixHealth Marks Hyperbaric Awareness Month with Nationwide Celebration RestorixHealth, a leading provider of wound care and hyperbaric center management services across the United States, has announced its participation in recognizing Hyperbaric Awareness Month this May. The annual observance, launched in…
Merck Finalizes Acquisition of Terns Pharmaceuticals, Strengthening Its Portfolio Merck & Co.—known as MSD outside the United States and Canada—has officially completed its acquisition of Terns Pharmaceuticals, marking a significant expansion of its oncology pipeline and reinforcing its long-term strategy…